Table 1.
Demographic and clinic characteristics of the patients.
| Characteristics |
Leukemia/
lymphoma (n = 41, 91.1%) |
Solid tumors (n = 4, 8.9%) | Overall (n = 45, 100%) | p-Value |
|---|---|---|---|---|
| Gender (n, %) | 0.626 | |||
| Female Male |
15, 36.6% 26, 63.4% |
2, 50% 2, 50% |
17, 37.8% 28, 62.2% | |
| Age (years) * | 7.5 (4.3–12.5) | 10 (3.9–16.5) | 7.5 (4.3–17.5) | 0.570 |
| Age group | 0.665 | |||
| 0–5 years 6–12 years >13 years |
11, 26.8% 18, 43.9% 12, 29.3% |
1, 25% 1, 25% 2, 50% |
12, 26.7% 19, 42.2% 14, 31.1% |
|
| Disease severity | 0.806 | |||
| Mild Moderate Severe |
19, 46.3% 18, 43.9% 4, 9.8 |
2, 50% 2, 50% – |
21, 46.7% 21, 44.4% 4, 8.9% |
|
| Hospital length of stay (days)* | 13 (8.5–17) | 13 (10.5–18.5) | 12.5 (9.2–17) | 0.154 |
| PICU length of stay (days)* | 4 (2, 25–22, 25) | – | 4 (2, 25–22, 25) | – |
| PICU requiring (n, %) | 4, 9.8% | – | 4, 8.9% | – |
| Steroid (n, %) | 8, 19.5% | – | 8, 17.8% | – |
| Favipiravir | 8, 19.5% | – | 8, 17.8% | – |
| Hydroxychloroquine | 1, 2.4% | – | 1, 2.2% | – |
| Chest CT (n, %) Normal Abnormal ** |
12, 57.1% 9, 42.9% |
3, 100% 0 |
15, 62.5% 9, 37.5% |
0.266 |
| Comorbidities (n, %) *** | 4, 9.8% | – | 4, 8.9% | – |
*
Median and interquartile range.
**
Ground-glass opacities, nodular lesions, pleural effusion, consolidation.
***
Diabetes mellitus (n = 1), cerebral venous sinus thrombosis (n = 1), dilated cardiomyopathy (n = 1), right atrial thrombus (n = 1).